Maiden Holdings, Ltd. 6.625 NT 2046
NYSE:MHLAInsurance - Property & Casualty
+$0.00 today
- Market cap
- $788.25M
- Beta
- 0.45
- P/E (TTM)
- -6.8
- EPS (TTM)
- -$1.68
- Dividend yield
- 14.50%
Volume 0.00M
Average 0.00M
MHLA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Maiden Holdings, Ltd. 6.625 NT 2046NYSE: MHLA
EBITDA · Q1 FY2025 · quarter ended Mar 2025
EBITDA turns negative
Q1 FY2025 EBITDA was -$3.82M, compared with $42.53M a year earlier. Trailing-twelve-month EBITDA was -$173.94M.
Context
- EBITDA amounted to 319.7% of revenue in FY2024, up 185.6 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2024 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly EBITDA holds near -$3.82M or moves back toward the trailing-twelve-month quarterly average of -$43.49M.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
USD · from the income statement
- Latest · FY2024
- (180.42M) USD
- Year-over-year change
- -250.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2024 | 2024-12-31 | (180.42M) | -250.8% |
| FY2023 | 2023-12-31 | 119.62M | +13.9% |
| FY2022 | 2022-12-31 | 104.99M | +8.6% |
| FY2021 | 2021-12-31 | 96.71M | +577.9% |
| FY2020 | 2020-12-31 | 14.27M | — |
EBITDA vs competitors
How MHLA compares with its peers on the latest reported figures
- MHLA's LTM Mar 2025 EBITDA of -$173.94M is the lowest of the 11 companies compared; the peer median is $137.45M.
- Its year-over-year change of -253.0% is the lowest of 11, against a peer median of +2.6%.
- EBITDA amounts to 418.3% of revenue for MHLA, versus a peer median of 13.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.38B | +21.5% | -1.8% | 16.9% | |
| LTM Sep 2026 | $672.68M | +14.6% | +24.1% | 12.4% | |
| LTM Mar 2026 | $384.75M | -13.6% | +7.9% | 48.1% | |
| LTM Sep 2026 | $340.6M | +13.8% | -2.0% | 24.0% | |
| FY2025 | $153.75M | -21.8% | — | 74.5% | |
| LTM Mar 2026 | $121.14M | +35.3% | +26.9% | 11.2% | |
| LTM Mar 2026 | $93.41M | -8.5% | +26.5% | 7.4% | |
| LTM Mar 2026 | $91.9M | -12.8% | — | 5.9% | |
| LTM Mar 2026 | -$6.22M | +97.5% | — | 6.3% | |
| LTM Mar 2026 | -$17.69M | -131.4% | — | 15.3% | |
| LTM Mar 2025 | -$173.94M | -253.0% | — | 418.3% | |
| Peer median (excluding MHLA) | $137.45M | +2.6% | +16.0% | 13.8% | |
Competitors are the stored peer set for MHLA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Revenue | 184.12M | 98.72M | 58.13M | 89.23M | 56.44M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 184.12M | 98.72M | 58.13M | 89.23M | 56.44M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 39.12M | 36.02M | 30.95M | 30.8M | 35.35M |
| Operating Expenses | 39.12M | 36.02M | 30.95M | 30.8M | 35.35M |
| Depreciation & Amortization | 6.24M | 3.45M | 49.32M | 2.75M | 233K |
| EBITDA | 14.27M | 96.71M | 104.99M | 119.62M | (180.42M) |
| EBITDA Margin | 7.7% | 98.0% | 180.6% | 134.1% | -319.7% |
| Operating Income | 145.01M | 62.7M | 27.19M | 58.44M | 21.09M |
| Operating Margin | 78.8% | 63.5% | 46.8% | 65.5% | 37.4% |
| Interest Income | 0 | 19.33M | 19.33M | 18.23M | (201.61M) |
| Interest Expense | 19.32M | 0 | 0 | 0 | 19.27M |
| Other Income / Expenses | (103.35M) | (36.04M) | (87.78M) | (96.81M) | (221M) |
| Income Before Tax | 41.66M | 26.66M | (60.6M) | (38.37M) | (199.91M) |
| Pre-Tax Margin | 22.6% | 27.0% | -104.2% | -43.0% | -354.2% |
| Income Tax Expense | (104K) | 15K | (557K) | 196K | 1.06M |
| Net Income | 41.76M | 26.65M | (60.04M) | (38.57M) | (200.97M) |
| Net Margin | 22.7% | 27.0% | -103.3% | -43.2% | -356.1% |
| EPS (Basic) | 0.93 | 1.35 | 0.63 | (0.38) | (2.01) |
| EPS (Diluted) | 0.93 | 1.35 | 0.63 | (0.38) | (2.01) |
| Weighted Avg Shares | 84.49M | 86.39M | 87.49M | 101.38M | 99.9M |
| Weighted Avg Shares (Diluted) | 84.33M | 86.07M | 87.11M | 101.38M | 99.9M |
Maiden Holdings, Ltd. 6.625 NT 2046
NYSE:MHLA
Intrinsic Alpha fair value
Locked
Current Price
$9.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.